Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Profit After Tax (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Profit After Tax for 16 consecutive years, with -$6.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax fell 161.49% to -$6.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.0 million, a 68.68% decrease, with the full-year FY2024 number at $42.1 million, down 34.06% from a year prior.
  • Profit After Tax was -$6.5 million for Q3 2025 at Usana Health Sciences, down from $9.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $40.4 million in Q4 2021 to a low of -$26.8 million in Q4 2022.
  • A 5-year average of $15.2 million and a median of $16.5 million in 2024 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: plummeted 185.27% in 2022, then soared 162.48% in 2023.
  • Usana Health Sciences' Profit After Tax stood at $40.4 million in 2021, then tumbled by 166.51% to -$26.8 million in 2022, then skyrocketed by 162.48% to $16.8 million in 2023, then plummeted by 73.26% to $4.5 million in 2024, then tumbled by 245.45% to -$6.5 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Profit After Tax are -$6.5 million (Q3 2025), $9.8 million (Q2 2025), and $9.3 million (Q1 2025).